Dark chocolate receptors: Epicatechin-induced cardiac protection is dependent on δ-opioid receptor stimulation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 299, Issue 5, 2010, Pages

  Panneerselvam, Mathivadhani ^a   Tsutsumi, Yasuo M ^a   Bonds, Jacqueline A ^a   Horikawa, Yousuke T ^a   Saldana, Michelle ^a   Dalton, Nancy D ^b   Head, Brian P ^a   Patel, Piyush M ^a,c   Roth, David M ^a,c   Patel, Hemal H ^a  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Ischemia reperfusion

Indexed keywords

5 HYDROXYDECANOIC ACID; CASPASE ACTIVATED DEOXYRIBONUCLEASE; DELTA OPIATE RECEPTOR; EPICATECHIN; I KAPPA B ALPHA; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CACAO; DRUG RECEPTOR BINDING; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION;

ANIMALS; CACAO; CATECHIN; DECANOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROXY ACIDS; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NALOXONE; NALTREXONE; POTASSIUM CHANNEL BLOCKERS; RECEPTORS, CELL SURFACE; RECEPTORS, OPIOID, DELTA;

EID: 78249257802     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00073.2010     Document Type: Article

References (36)

1. Bayard V, Chamorro F, Motta J, Hollenberg NK. Does flavanol intake influence mortality from nitric oxide-dependent processes? Ischemic heart disease, stroke, diabetes mellitus, and cancer in Panama. Int J Med Sci 4: 53-58, 2007.
2. Bubici C, Papa S, Pham CG, Zazzeroni F, Franzoso G. The NF-kappaB-mediated control of ROS and JNK signaling. Histol Histopathol 21: 69-80, 2006.
3. ATP channels. Am J Physiol Heart Circ Physiol 285: H1032-H1039, 2003.
4. Capasso A. The effect of flavonol glycosides on opiate withdrawal. Med Chem 3: 327-331, 2007.
5. Capasso A, Piacente S, Pizza C, Sorrentino L. Flavonoids reduce morphine withdrawal in-vitro. J Pharm Pharmacol 50: 561-564, 1998.
6. Capasso A, Saturnino P, Simone FD, Aquino R. Flavonol glycosides from Aristeguietia discolor reduce morphine withdrawal in vitro. Phytother Res 14: 538-540, 2000.
7. Downey JM, Krieg T, Cohen MV. Mapping preconditioning's signaling pathways: an engineering approach. Ann NY Acad Sci 1123: 187-196, 2008.
8. Engler MB, Engler MM. The emerging role of flavonoid-rich cocoa and chocolate in cardiovascular health and disease. Nutr Rev 64: 109-118, 2006.
9. Erdman JW Jr, Carson L, Kwik-Uribe C, Evans EM, Allen RR. Effects of cocoa flavanols on risk factors for cardiovascular disease. Asia Pac J Clin Nutr 17, Suppl 1: 284-287, 2008.
10. Flammer AJ, Hermann F, Sudano I, Spieker L, Hermann M, Cooper KA, Serafini M, Luscher TF, Ruschitzka F, Noll G, Corti R. Dark chocolate improves coronary vasomotion and reduces platelet reactivity. Circulation 116: 2376-2382, 2007.
11. Fryer RM, Hsu AK, Gross GJ. ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res Cardiol 96: 136-142, 2001.
12. Gross GJ, Peart JN. Opioids and myocardial reperfusion injury. Arch Mal Coeur Vaiss 100: 231-237, 2007.
13. Hendrich AB. Flavonoid-membrane interactions: possible consequences for biological effects of some polyphenolic compounds. Acta Pharmacol Sin 27: 27-40, 2006.
14. Hollenberg NK. Vascular action of cocoa flavanols in humans: the roots of the story. J Cardiovasc Pharmacol 47, Suppl 2: S99-S102; discussion S119-S121, 2006.
15. Katavic PL, Lamb K, Navarro H, Prisinzano TE. Flavonoids as opioid receptor ligands: identification and preliminary structure-activity relationships. J Nat Prod 70: 1278-1282, 2007.
16. Maleki-Dizaji N, Fathiazad F, Garjani A. Antinociceptive properties of extracts and two flavonoids isolated from leaves of Danae racemosa. Arch Pharm Res 30: 1536-1542, 2007.
17. Maslov LN, Lishmanov YB, Oeltgen PR, Barzakh EI, Krylatov AV, Govindaswami M, Brown SA. Activation of peripheral delta2 opioid receptors increases cardiac tolerance to ischemia/reperfusion injury Involvement of protein kinase C, NO-synthase, KATP channels and the autonomic nervous system. Life Sci 84: 657-663, 2009.
18. Maulik N, Goswami S, Galang N, Das DK. Differential regulation of Bcl-2, AP-1 and NF-kappaB on cardiomyocyte apoptosis during myocardial ischemic stress adaptation. FEBS Lett 443: 331-336, 1999.
19. Mukherjee S, Lekli I, Das M, Azzi A, Das DK. Cardioprotection with alpha-tocopheryl phosphate: amelioration of myocardial ischemia reperfusion injury is linked with its ability to generate a survival signal through Akt activation. Biochim Biophys Acta 1782: 498-503, 2008.
20. Oteiza PI, Erlejman AG, Verstraeten SV, Keen CL, Fraga CG. Flavonoid-membrane interactions: a protective role of flavonoids at the membrane surface? Clin Dev Immunol 12: 19-25, 2005.
21. Patel HH, Ludwig LM, Fryer RM, Hsu AK, Warltier DC, Gross GJ. Delta opioid agonists and volatile anesthetics facilitate cardioprotection via potentiation of KATP channel opening. FASEB J 16: 1468-1470, 2002.
22. Patra SK, Rizzi F, Silva A, Rugina DO, Bettuzzi S. Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts. J Physiol Pharmacol 59, Suppl 9: 217-235, 2008.
23. Peart JN, Gross GJ. Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways. Am J Physiol Heart Circ Physiol 291: H1746-H1753, 2006.
24. Ramiro-Puig E, Castell M. Cocoa: antioxidant and immunomodulator. Br J Nutr 101: 931-940, 2009.
25. Schroeter H, Bahia P, Spencer JP, Sheppard O, Rattray M, Cadenas E, Rice-Evans C, Williams RJ. (-)Epicatechin stimulates ERK-dependent cyclic AMP response element activity and up-regulates GluR2 in cortical neurons. J Neurochem 101: 1596-1606, 2007.
26. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C, Schmitz HH, Kelm M. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 103: 1024-1029, 2006.
27. Schultz JJ, Hsu AK, Gross GJ. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart. J Mol Cell Cardiol 29: 2187-2195, 1997.
28. Selmi C, Mao TK, Keen CL, Schmitz HH, Eric Gershwin M. The anti-inflammatory properties of cocoa flavanols. J Cardiovasc Pharmacol 47, Suppl 2: S163-S171; discussion S172-S166, 2006.
29. Spencer JP, Schroeter H, Kuhnle G, Srai SK, Tyrrell RM, Hahn U, Rice-Evans C. Epicatechin and its in vivo metabolite, 3′-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation. Biochem J 354: 493-500, 2001.
30. Steffen Y, Schewe T, Sies H. Myeloperoxidase-mediated LDL oxidation and endothelial cell toxicity of oxidized LDL: attenuation by (-)-epicatechin. Free Radic Res 40: 1076-1085, 2006. (Pubitemid 44480548)
31. Taubert D, Roesen R, Lehmann C, Jung N, Schomig E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA 298: 49-60, 2007. (Pubitemid 47026770)
32. Trang T, Sutak M, Quirion R, Jhamandas K. Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone-precipitated opioid withdrawal. Br J Pharmacol 140: 295-304, 2003. (Pubitemid 37249189)
33. Trumbeckaite S, Bernatoniene J, Majiene D, Jakstas V, Savickas A, Toleikis A. The effect of flavonoids on rat heart mitochondrial function. Biomed Pharmacother 60: 245-248, 2006. (Pubitemid 43975717)
34. Tsutsumi YM, Patel HH, Lai NC, Takahashi T, Head BP, Roth DM. Isoflurane produces sustained cardiac protection after ischemia-reperfusion injury in mice. Anesthesiology 104: 495-502, 2006.
35. Xu JZ, Yeung SY, Chang Q, Huang Y, Chen ZY. Comparison of antioxidant activity and bioavailability of tea epicatechins with their epimers. Br J Nutr 91: 873-881, 2004. (Pubitemid 38931451)
36. Yamazaki KG, Romero-Perez D, Barraza-Hidalgo M, Cruz M, Rivas M, Cortez-Gomez B, Ceballos G, Villarreal F. Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 295: H761-H767, 2008.